Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003474466 | SCV004211468 | pathogenic | Biotinidase deficiency | 2023-04-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003474466 | SCV005834610 | pathogenic | Biotinidase deficiency | 2024-08-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu46*) in the BTD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BTD are known to be pathogenic (PMID: 20083419). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with biotinidase deficiency (PMID: 17185019). For these reasons, this variant has been classified as Pathogenic. |